Kenai Therapeutics

Kenai Therapeutics is a biotech company in San Diego, United States, founded in 2022. It has raised $90.0M across 2 rounds, most recently an $8.0M Grant in January 2026.

Pioneering next generation approaches to cure neurological conditions.

Employees
11–50
Founded
2022
Total Funding
$90.0M
Last Round
$8.0M GrantJan 2026
Rounds
2

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 2 funding rounds and 4 investors for this company. The full record is or through the API.

About

Kenai Therapeutics is a clinical-stage biotechnology company developing off-the-shelf dopamine-neuron replacement cell therapies and gene-modified medicines for neurological conditions. Its programs aim to provide disease-modifying or potentially curative treatments that go beyond symptom management for neurodegenerative disease. The company focuses on restoring function and quality of life through next-generation approaches to neuron replacement and neurological-cell therapy.

Summary

It lists 11–50 employees. It has raised $90.0M in total across 2 rounds, most recently a $8.0M Grant round in Jan 2026. Investors include Alaska Permanent Fund, Cure Ventures and The Column Group.

Funding History

Data from Indexed.vcUpdated
GrantCIRM GrantJan 2026
$8.0M

Sign up to see all 2 events

Funding: Grant. Amounts, valuations, and investors where available.

Investors

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Kenai Therapeutics on Indexed.vc
<a href="https://indexed.vc/companies/kenai-therapeutics"><img src="https://indexed.vc/api/badge/company/kenai-therapeutics" alt="Kenai Therapeutics on Indexed.vc" width="260" height="76" /></a>